BANTOCK, Pete
To:Accelerate Diagnostics Inc., Chief Commercial Officer (July)
Execs On The Move, September 2013
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
More from Archive
More from In Vivo
• By
MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.
• By
In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.
• By
Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.